Hospira Woes Continue As Glass Contamination Spurs Recall

By Jeff Overley (October 3, 2013, 4:58 PM EDT) -- Beleaguered drugmaker Hospira Inc. on Tuesday said it's recalling three lots of injectable drugs because the vials contain glass strands that could dislodge and harm patients, the latest addition to a laundry list of recent manufacturing problems for the pharmaceutical giant.

In a statement, Hospira blamed a supplier for defects that it said might cause minor injuries, such as vein inflammation, if glass particulates were to detach from the inner walls of vials and be injected into a patient. It's also possible that the fragments could cause organ damage by blocking blood flow in vulnerable individuals, such as children, the elderly...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!